| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.085 | 0.06 |